QuickView for antigen processing and presentation of peptide antigen via MHC class II (biogroup)

1. Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
2. Follicular fluid miRNA profiles during the development of the oocyte
3. Calu-3 lung adenocarcinoma cells infected with wildtype and mutant SARS virus
4. miRNA expression profiles from osteosarcoma samples and cell lines
5. Expression data for effector T cells

There were no matches for antigen processing and presentation of peptide antigen via MHC class II

1. Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
2. Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
3. WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transpla…
4. Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
5. Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Ado…